Since PUFAs cannot be synthesized de novo, mesenchymal cancers regulate the ratio of PLs with PUFAs and MUFAs by upregulating ACSL4, fatty acid desaturase 2 (FADS2), and ELOVL fatty acid elongase 5 (ELOVL5). The gene discussed is FADS2; the disease is cancer.